HUTCHMED (China) (HCM) Total Debt Growth (3y) (2018 - 2026)
HUTCHMED (China) (HCM) Total Debt Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 15.43% |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -7.08% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.33% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -3.67% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -10.43% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -13.72% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 92.83% |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.71% |
| Dec 31, 2025 | 72.98% |
| Jun 30, 2025 | 381.71% |
| Dec 31, 2024 | 45.56% |
| Jun 30, 2024 | 45.08% |
| Dec 31, 2023 | 2,836.55% |
| Jun 30, 2023 | 16.19% |
| Dec 31, 2022 | 84.92% |
| Dec 31, 2021 | -49.72% |
| Jun 30, 2021 | -10.41% |
| Dec 31, 2020 | -61.49% |
| Jun 30, 2020 | -1.57% |
| Dec 31, 2019 | -77.50% |
| Dec 31, 2018 | -6.28% |